Salgi Esophageal Cancer Research Foundation is located in East Greenwich, RI. The organization was established in 2012. According to its NTEE Classification (H40) the organization is classified as: Diseases of Specific Organs Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Salgi Esophageal Cancer Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 11/2023, Salgi Esophageal Cancer Research Foundation generated $100.8k in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 6.8% each year. All expenses for the organization totaled $147.4k during the year ending 11/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE ORGANIZATION'S MISSION IS TO RAISE FUNDS FOR AWARENESS, EARLY DETECTION AND RESEARCH OF ESOPHAGEAL CANCER IN HOPES OF A CURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
AWARENESS AND EARLY DETECTION PROGRAMS VIA SOCIAL MEDIA, WEBSITE, EMAIL MARKETING, PRINT, MAILING, AND OTHER MEDIA OUTLETS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Christina M Frye Vice President | OfficerTrustee | 10 | $9,600 |
James W Frye Secretary | OfficerTrustee | 10 | $0 |
Linda M Molfesi President & Treasurer | OfficerTrustee | 10 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $56 |
Membership dues | $0 |
Fundraising events | $55,620 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $44,621 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $100,297 |
Total Program Service Revenue | $0 |
Investment income | $2,407 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | -$1,923 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $100,781 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $124,742 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $9,443 |
Compensation of current officers, directors, key employees. | $3,148 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $933 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $2,375 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $772 |
Advertising and promotion | $377 |
Office expenses | $2,505 |
Information technology | $1,238 |
Royalties | $0 |
Occupancy | $0 |
Travel | $674 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,275 |
All other expenses | $0 |
Total functional expenses | $147,370 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $256,157 |
Savings and temporary cash investments | $250,000 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $2,200 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $508,357 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $508,357 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $508,357 |
Over the last fiscal year, Salgi Esophageal Cancer Research Foundation has awarded $124,742 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
H LEE MOFFITT CANCER & RESEARCH INSTITUTE INC PURPOSE: RESEARCH | $30,000 |
INDIANA UNIVERSITY PURPOSE: RESEARCH | $50,000 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA PURPOSE: RESEARCH | $44,742 |
Organization Name | Assets | Revenue |
---|---|---|
National Scleroderma Foundation Danvers, MA | $12,897,422 | $6,915,898 |
Termeer Foundation Inc Marblehead, MA | $1,796,459 | $1,212,552 |
Usher 1f Collaborative Inc Newtonville, MA | $1,300,335 | $1,082,978 |
Salgi Esophageal Cancer Research Foundation East Greenwich, RI | $508,357 | $100,781 |
Domar Foundation Inc Waltham, MA | $0 | $0 |
Cgat Research Foundation Inc Needham, MA | $17,853 | $0 |